Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma — Meletios A Dimopoulos (2009) | RDL Network
Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma
Meletios A Dimopoulos, Andrew Spencer, Michael Attal, Miles Prince, Jean‐Luc Harousseau, Anna Dmoszyńska, Zhinuan Yu, Marta Olesnyckyj, Jerome B. Zeldis, Robert Knight
Meletios A Dimopoulos, Andrew Spencer, Michael Attal, H. Miles Prince, Jean‐Luc Harousseau, Anna Dmoszyńska, Jesús F. San Miguel, Andrzej Hellmann, Thierry Façon, Robin Foà, Alessandro Corso, Zvenyslava Masliak, Marta Olesnyckyj, Zhinuan Yu, John Patin, Jerome B. Zeldis, Robert Knight
David S. Siegel, Meletios A Dimopoulos, Heinz Ludwig, Thierry Façon, Hartmut Goldschmidt, Andrzej Jakubowiak, Jesús F. San Miguel, Mihaela Obreja, Julie Blædel, A. Keith Stewart
Meletios A Dimopoulos, Katja Weisel, Sagar Lonial, Darrell White, Philippe Moreau, María‐Victoria Mateos, Jesús F. San Miguel, Kenneth C. Anderson, Ofer Shpilberg, Sebastian Grosicki, Ivan Špıčka, Adam Walter‐Croneck, Hila Magen, Andrew R. Belch, Donna Reece, Meral Beksaç, Alex Ganetsky, Ying‐Ming Jou, Mihaela Popa McKiver, Anil Singhal, Paul G. Richardson
Discussion(0)
No comments yet. Be the first to comment.